Preliminary study of astragaloside IV on oxaliplatin-induced peripheral neurotoxicity in rats

Preliminary study of astragaloside IV on oxaliplatin-induced peripheral neurotoxicity in rats

Objective : As an effective component of Astragalus membranaceus , astragaloside IV (AS-IV) has a history of thousands of years in China. Many evidences have indicated that AS-IV has a potential neuroprotective effect. In this study, we aimed to preliminarily study the effects of AS-IV on oxaliplati...

Full description

Bibliographic Details
Main Authors:	Lanjuan Yi, Shan Li, Aihua Hou, Lingling Dai
Format:	Article
Language:	English
Published:	SAGE Publishing 2022-04-01
Series:	European Journal of Inflammation
Online Access:	https://doi.org/10.1177/1721727X221094157

Similar Items

Network Pharmacology and Experimental Evidence Identify the Mechanism of Astragaloside IV in Oxaliplatin Neurotoxicity
by: Xu J, et al.
Published: (2021-01-01)

Predictive Biomarkers of Oxaliplatin-Induced Peripheral Neurotoxicity
by: Roser Velasco, et al.
Published: (2021-07-01)

Updates on Oxaliplatin-Induced Peripheral Neurotoxicity (OXAIPN)
by: Andreas A. Argyriou
Published: (2015-05-01)

RETRACTED: Molecular mechanism of electroacupuncture treatment on oxaliplatin-induced peripheral neurotoxicity in rats
by: Du Shanshan, et al.
Published: (2020-10-01)

RETRACTION NOTICE: Molecular mechanism of electroacupuncture treatment on oxaliplatin-induced peripheral neurotoxicity in rats
Published: (2023-02-01)

Therapeutic effects of astragaloside IV and Astragalus spinosus saponins against bisphenol A-induced neurotoxicity and DNA damage in rats
by: Amina E. Essawy, et al.
Published: (2021-08-01)

Astragaloside IV Attenuates Glutamate-Induced Neurotoxicity in PC12 Cells through Raf-MEK-ERK Pathway.
by: Rongcai Yue, et al.
Published: (2015-01-01)

The Effect of Astragaloside IV on Isoproterenol-Induced Myocardial Infarction in Rats
by: Fatemeh Fathizad, et al.
Published: (2019-06-01)

Oxaliplatin-induced peripheral neurotoxicity in colorectal cancer patients: mechanisms, pharmacokinetics and strategies
by: Fang Cheng, et al.
Published: (2023-08-01)

Effects of astragaloside IV on the pharmacokinetics of omeprazole in rats
by: Wei Liu, et al.
Published: (2019-01-01)

Effects of puerarin on the pharmacokinetics of astragaloside IV in rats and its potential mechanism
by: Huan Zhang, et al.
Published: (2020-01-01)

Antineuropathic profile of N-palmitoylethanolamine in a rat model of oxaliplatin-induced neurotoxicity.
by: Lorenzo Di Cesare Mannelli, et al.
Published: (2015-01-01)

Pharmacokinetic study on the co-administration of abemaciclib and astragaloside IV in rats
by: Sen Sun, et al.
Published: (2022-12-01)

The Incidence of Oxaliplatin-Induced Peripheral Neurotoxicity at Khartoum Oncology Hospital: A Cross-Sectional Survey
by: Nadeen T Ali, et al.
Published: (2020-01-01)

Protective effect of Astragaloside IV against sepsis-induced acute lung injury in rats
by: Ruiqin Huang, et al.
Published: (2016-05-01)

Monosialotetrahexosylganglioside in the treatment of chronic oxaliplatin-induced peripheral neurotoxicity: TJMUCH-GI-001, a randomised controlled trial
by: Likun Zhou, et al.
Published: (2021-11-01)

Susceptibility of different mouse strains to oxaliplatin peripheral neurotoxicity: Phenotypic and genotypic insights.
by: Paola Marmiroli, et al.
Published: (2017-01-01)

Gastroprotective Effects of Astragaloside IV against Acute Gastric Lesion in Rats.
by: Shuai Mao, et al.
Published: (2016-01-01)

Sodium-Calcium Exchanger 2: A Pivotal Role in Oxaliplatin Induced Peripheral Neurotoxicity and Axonal Damage?
by: Elisa Ballarini, et al.
Published: (2022-09-01)

Ganglioside-monosialic acid (GM1) prevents oxaliplatin-induced peripheral neurotoxicity in patients with gastrointestinal tumors
by: Zhu Yanyun, et al.
Published: (2013-01-01)

Untapping the Potential of Astragaloside IV in the Battle Against Respiratory Diseases
by: Tan J, et al.
Published: (2023-07-01)

Astragaloside IV Improves Bleomycin-Induced Pulmonary Fibrosis in Rats by Attenuating Extracellular Matrix Deposition
by: Liu-Cheng Li, et al.
Published: (2017-08-01)

Influence of astragaloside IV on pharmacokinetics of triptolide in rats and its potential mechanism
by: Jian Gao, et al.
Published: (2020-01-01)

Anti-Fibrotic Effects of Astragaloside IV in Systemic Sclerosis
by: Qing Qi, et al.
Published: (2014-11-01)

Therapeutic Potential of Astragaloside IV Against Adriamycin-Induced Renal Damage in Rats via Ferroptosis
by: Lu-Yun Qin, et al.
Published: (2022-03-01)

Inhibition of NHE1 transport activity and gene transcription in DRG neurons in oxaliplatin-induced painful peripheral neurotoxicity
by: Marianna Dionisi, et al.
Published: (2023-03-01)

Astragaloside IV, as a potential anticancer agent
by: Dongqin Xia, et al.
Published: (2023-02-01)

Astragaloside Ⅳ reduces renal vascular endothelial injury in uremic rat model
by: ZHU Wen-sheng, ZHENG Zhong-yu, LI Xiao-xia, DENG Jian-nan, ZHANG Ji-chun
Published: (2021-11-01)

Analgesic Effect of Melittin on Oxaliplatin-Induced Peripheral Neuropathy in Rats
by: Seunghwan Choi, et al.
Published: (2019-07-01)

Research progress on the mechanism of astragaloside IV in the treatment of asthma
by: Fanyi Yuan, et al.
Published: (2023-11-01)

Protective effects of astragaloside IV against amyloid beta1-42 neurotoxicity by inhibiting the mitochondrial permeability transition pore opening.
by: Qinru Sun, et al.
Published: (2014-01-01)

Pharmacological Effects of Astragaloside IV: A Review
by: Yutong Liang, et al.
Published: (2023-08-01)

Astragaloside IV Improves Metabolic Syndrome and Endothelium Dysfunction in Fructose-Fed Rats
by: Feng Zhao, et al.
Published: (2011-05-01)

Astragaloside IV: An Effective Drug for the Treatment of Cardiovascular Diseases
by: Tan YQ, et al.
Published: (2020-09-01)

Protective effects of astragaloside IV against hypertension-induced vascular remodeling involves the DNMT1 and TET2 signaling pathway
by: Qin Yingchun, et al.
Published: (2021-01-01)

Astragaloside IV Ameliorates Myocardial Infarction Induced Apoptosis and Restores Cardiac Function
by: Chuang Sun, et al.
Published: (2021-07-01)

Exenatide Facilitates Recovery from Oxaliplatin-Induced Peripheral Neuropathy in Rats.
by: Shunsuke Fujita, et al.
Published: (2015-01-01)

Effect of green tea extracts on oxaliplatin-induced peripheral neuropathy in rats
by: Lee Jung, et al.
Published: (2012-08-01)

Astragalus polysaccharides and astragaloside IV ameliorates cyclophosphamide-induced mouse model of overactive bladder
by: Yung-Hsiang Chen, et al.
Published: (2020-03-01)

Calmangafodipir Reduces Sensory Alterations and Prevents Intraepidermal Nerve Fibers Loss in a Mouse Model of Oxaliplatin Induced Peripheral Neurotoxicity
by: Annalisa Canta, et al.
Published: (2020-07-01)